After IonQ’s stock jumped on news of its quantum error correction decoder, several Wall Street firms already had recent ratings and price targets on the stock. Here’s how they stack up.
Where each firm stands
| Firm | Rating | Price Target | Recent Change |
|---|---|---|---|
| Wedbush | Outperform | $75 | Maintained |
| Mizuho | Outperform | $52 | Lowered (from a higher prior target) |
| Rosenblatt | Buy | $100 | Maintained |
Rosenblatt holds the highest target of the three at $100, while Mizuho’s $52 target is the most conservative, even though Mizuho’s rating itself — Outperform — is still positive.
The consensus view
Across analysts covering IonQ, the overall consensus rating is Buy, with an average price target of $67.75. That average sits between the more cautious Mizuho figure and the more bullish Wedbush and Rosenblatt targets.
What the spread tells you
The gap between $52 and $100 is wide, which reflects real disagreement among analysts about how much of IonQ’s future growth is already priced into the stock — not a single, settled view of fair value. A rating being “maintained” (Wedbush, Rosenblatt) versus a target being “lowered” (Mizuho) also signals different levels of conviction even among analysts who are all technically positive on the stock.
Price targets get revised as new information comes in, so it’s worth checking for updated analyst notes rather than treating any single number as fixed.
Sources / Learn more
Related reading
- What does Cantor Fitzgerald’s price target increase to $608 suggest about Microsoft stock’s upside from current levels?
- What price levels should investors watch to see if PLTR stock breaks out toward $200 or pulls back toward $164?
Leave a Reply